Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SEPN | LIME |
|---|---|---|
| Price | $37.87 | $27.17 |
| Change today | ▲ 0.42% | ▼ 0.18% |
| Market cap | $1.77B | $1.77B |
| Return, 3 months | +5.7% | +12.5% |
| Return, year to date | +35.8% | – |
| Return, 1 year | +82.1% | – |
| P/E (TTM) | -71.5 | 8.4 |
| P/B | 4.6 | 2.6 |
| P/E percentile vs own 5y | – | 43rd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +22,375.6% | – |
| Net profit growth (YoY) | +47.5% | – |
| Gross margin | – | – |
| Operating margin | -62.9% | – |
| Net margin | -48.7% | – |
| Return on equity | – | – |
| Analyst target vs. price | +39.6% | +44.6% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 46 | 33 |
| 30-day volatility | 36.5% | 54.0% |
| Max drawdown, 1 year | -25.2% | -37.2% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
